½ÃÀ庸°í¼­
»óǰÄÚµå
1527269

¼¼°èÀÇ Èä°­ ¹è¾× ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç°º°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Chest Drainage Systems Market Size Study, by Product, by Indication, by End-user and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2023³â ¾à 10¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2024-2032³â ¿¹Ãø ±â°£ µ¿¾È 5.7% ÀÌ»óÀÇ °Ç°­ÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á ºÐ¾ß¿¡¼­ Èä°­ ¹è¾× ½Ã½ºÅÛÀº ƯÈ÷ ÈäºÎ ¼ö¼ú ¹× Æó ÀÇÇÐ ºÐ¾ß¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. Èä°­ ³» °ø±â, Ç÷¾× ¹× ±âŸ ü¾×À» Á¦°ÅÇÏ¿© ±ÔÄ¢ÀûÀΠȣÈí °úÁ¤À» ´Ù½Ã È®¸³ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ±âÈä ¹× Èä¼ö Àú·ù¿Í °°Àº ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â ÀÌ ÀåÄ¡´Â ¿øÄ¡ ¾Ê´Â ¹°ÁúÀÇ ¹èÃâÀ» ÃËÁøÇϸç ÀϹÝÀûÀ¸·Î ¼öÁý è¹ö¿Í ¹° ¹ÐºÀÀ¸·Î ±¸¼ºµË´Ï´Ù. Èä°­ ¹è¾× ½Ã½ºÅÛÀº ±× È¿°ú¿Í ÀÎü°øÇÐÀû ¼³°è·Î ÀÎÇØ ÈäºÎ Áúȯ Ä¡·á¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº Å©°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, ±× ¹è°æ¿¡´Â ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÈäºÎ Áúȯ¿¡ Ãë¾àÇÑ °í·ÉÈ­·Î ÀÎÇØ Èä°­ ¹è¾× ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½ÀÀû ½Ã¼ú°ú µðÁöÅÐ ¹è¾× ½Ã½ºÅÛÀÇ °³¹ß µî ±â¼úÀÇ ¹ßÀüÀ¸·Î Àü¹ÝÀûÀÎ È¿°ú¿Í ȯÀÚ ¸¸Á·µµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¶±â °³ÀÔÀ» À§ÇÑ Èä°­ ¹è¾× ½Ã½ºÅÛ µµÀÔÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ·áÁøÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå È®´ë¸¦ À̲ô´Â Áß¿äÇÑ ¿äÀÎÀº È£Èí±â ÁúȯÀÇ ¹ß»ý·ü Áõ°¡ÀÔ´Ï´Ù. ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD)¿¡¼­ ÆóÀÇ ¾Ç¼º Á¾¾ç¿¡ À̸£±â±îÁö È£Èí±â ÁúȯÀÇ Áõ°¡´Â ¼¼°èÀûÀÎ °Ç°­ ¹®Á¦·Î Àνĵǰí ÀÖ½À´Ï´Ù. ȯ°æ¿À¿°, »ýȰ½À°ü ¿äÀÎ, ´ã¹è º¸±Þ·ü Áõ°¡ µîÀÌ ¸ðµÎ È£Èí±â ÁúȯÀÇ ºÎ´ãÀ» Áõ°¡½ÃŰ´Â ¿øÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÇöÀç Áõ°¡ÇÏ´Â »ç·Ê´Â È¿°úÀûÀÎ ÀÇ·á °³ÀÔÀÇ Á߿伺À» °­Á¶ÇÒ »Ó¸¸ ¾Æ´Ï¶ó Èä°­ ¹è¾× ½Ã½ºÅÛÀÌ ÀÌ·¯ÇÑ ÁúȯÀÇ ÀüÀÎÀû Ä¡·á¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÓÀ» ÀÔÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ÏÀ¸·Î ÀÎÇÑ »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀÎ Æó¾ÏÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÈäºÎ ¼ö¼ú ¹× ½Ã¼úÀÌ ÇÊ¿äÇϸç, ¼ö¼ú ÈÄ °ü¸®¿¡´Â Èä°­ ¹è¾× ½Ã½ºÅÛÀÌ ÇÊ¿äÇÕ´Ï´Ù. È£Èí±â ÁúȯÀÇ Àü ¼¼°è À¯º´·ü Áõ°¡¸¦ °í·ÁÇÒ ¶§ Èä°­ ¹è¾× ½Ã½ºÅÛ ½ÃÀåÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÌ·¯ÇÑ ±¤¹üÀ§ÇÑ Áúº´°ú °ü·ÃµÈ ÀÌȯÀ²À» ÁÙÀÌ´Â Áß¿äÇÑ ±â´É¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀ» ÃËÁøÇÏ´Â À¯¸®ÇÑ ¿äÀÎÀº ÃÖ¼Òħ½À ¼ö¼ú ±â¼úÀÇ »ç¿ë È®´ëÀÔ´Ï´Ù. ÀÇ·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú ÇÔ²² ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼ÀÇ ¹è°æ¿¡´Â ȯÀÚÀÇ ¿Ü»óÀ» ÁÙÀ̰í, ȸº¹ ±â°£À» ´ÜÃàÇϸç, ÀÇ·á °á°ú¸¦ °³¼±Çϱâ À§ÇÑ ¸ñÀûÀÌ ÀÖ½À´Ï´Ù.

ºÏ¹Ì°¡ ¼¼°è Èä°­ ¹è¾× ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ±â¼ú ¹ßÀü, Á¤±³ÇÑ ÀÇ·á ÀÎÇÁ¶ó, È£Èí±â ÁúȯÀÇ ³ôÀº À¯º´·ü µîÀÌ ÀÌ Áö¿ªÀÇ ¿ìÀ§ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹, ij³ª´Ù µîÀÇ ±¹°¡¿¡¼­ Àß ±¸ÃàµÈ ÀÇ·á ½Ã½ºÅÛÀº Èä°­ ¹è¾× ½Ã½ºÅÛ°ú °°Àº ÷´Ü ÀÇ·á ±â¼úÀÇ ÅëÇÕ¿¡ À¯¸®ÇÑ È¯°æÀ» Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå¿¡¼­ ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ºü¸¥ ¼ºÀå¿¡´Â ¿©·¯ °¡Áö ¿äÀÎÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áß±¹, Àεµ¿Í °°Àº Àα¸ ¹ÐÁý ±¹°¡¿¡¼­´Â È£Èí±â ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Èä°­ ¹è¾× ½Ã½ºÅÛ°ú °°Àº ÈäºÎ ÁßÀç¼ú¿¡ ´ëÇÑ ¼ö¿äÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó °­È­, °æÁ¦ ¼ºÀå, ÀÇ·á ÀÎ½Ä °³¼±Àº ÀÌ Áö¿ªÀÌ ÃÖ÷´Ü ÀÇ·á ¼­ºñ½º¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • Á¦Ç°º°
    • ÀûÀÀÁõº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±âÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦2Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå Á¤ÀÇ¿Í Á¶»ç °¡Á¤

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç °¡Á¤
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ»çÇ×
    • °ø±ÞÃø ºÐ¼®
      • ÀÔ¼ö °¡´É¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ °üÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • È£Èí±âÁúȯ À¯º´·ü Áõ°¡
    • ±â¼úÀÇ Áøº¸
    • ÃÖ¼Òħ½À ¼ö¼ú ¼ö¿ä
  • ½ÃÀå °úÁ¦
    • ÷´Ü ½Ã½ºÅÛÀÇ °íºñ¿ë
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ³ë³â Àα¸ Áõ°¡
    • ½ÅÈï ½ÃÀå¿¡¼­ÀÇ È®´ë

Á¦4Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨·ÎÀÇ ¹Ì·¡ÁöÇâÀû Á¢±Ù¹ý
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç°º°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå : Á¦Ç°º° ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • Èä°­ ¹è¾× ½Ã½ºÅÛ
    • Èä°­ ¹è¾× ½Ã½ºÅÛ Å°Æ®
    • Èä°­ ¹è¾× ½Ã½ºÅÛ ¾×¼¼¼­¸®

Á¦6Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÀûÀÀÁõº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ÀûÀÀÁõº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • Èä¼ö
    • Ç÷Èä
    • ÀÚ¿¬ ±âÈä
    • ±äÀ强 ±âÈä
    • ¿Ü»ó¼º ±âÈä
    • ½ÉŽÆ÷³×À̵å
    • °ü»óµ¿¸Æ ¿ìȸ¼ú(CABG)
    • °³½É¼ú

Á¦7Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • º´¿ø
    • Àü¹® Ŭ¸®´Ð
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦8Àå Èä°­ ¹è¾× ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Teleflex Incorporated
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • B. Braun Melsungen AG
    • Smiths Medical(ICU Medical Inc.)
    • Becton, Dickinson and Company
    • Cardinal Health
    • Redax S.p.A.
    • Merit Medical Systems
    • Getinge AB
    • Rocket Medical plc.
    • Grena Ltd.
    • Sterimed Group
    • pfm medical ag
    • Medela AG
    • Sinapi Biomedical
    • ATMOS MedizinTechnik GmbH & Co. KG

Á¦10Àå Á¶»ç °úÁ¤

ksm 24.08.27

Global Chest Drainage Systems Market is valued approximately at USD 1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2024-2032. In the medical sector, chest drainage systems are indispensable, especially in thoracic surgery and pulmonary medicine. By removing air, blood, or other bodily fluids from the pleural cavity, these mechanisms assist in the re-establishment of regular respiratory processes. These devices, which prevent complications like pneumothorax and pleural effusion, facilitate the evacuation of undesirable substances and typically comprise a collection chamber and a water seal. After their inception, contemporary chest drainage systems have become indispensable in the treatment of thoracic disorders due to their enhanced efficacy and ergonomics.

The global market for chest drainage systems is experiencing substantial expansion, which can be attributed to a multitude of factors. The growing prevalence of respiratory disorders, in conjunction with an aging population that is more susceptible to thoracic maladies, has contributed to the increased need for these systems. Technological advancements, including the creation of minimally invasive procedures and digital drainage systems, have improved the overall efficacy and satisfaction of patients. Furthermore, the increasing recognition among healthcare practitioners regarding the advantages of implementing chest drainage systems for early intervention has additionally fuelled the growth of the market.

An important factor propelling the expanding global market for chest drainage systems is the rising incidence of respiratory conditions. An increasing number of respiratory conditions, ranging from chronic obstructive pulmonary disease (COPD) to lung malignancy, have been identified as a global health concern. Environmental pollution, lifestyle factors, and the increasing prevalence of tobacco use all contribute to the escalating burden of respiratory diseases. The current increase in cases not only highlights the critical nature of effective medical interventions but also establishes thoracic drainage systems as an essential element in the holistic treatment of these conditions. Moreover, the escalating prevalence of lung cancer, which is the primary contributor to mortality from cancer, requires thoracic operations and procedures in which postoperative care requires chest drainage systems. In the light of the increasing prevalence of respiratory diseases worldwide, the market for chest drainage systems is driven by its critical function of enhancing patient outcomes and mitigating the morbidity linked to these widespread ailments.

An opportunistic factor propelling the global market for thoracic drainage systems is the expanding use of minimally invasive surgical techniques. With the continuous advancement of medical technology, there is an increasing trend towards minimally invasive interventions. This trend is motivated by the aim to reduce patient trauma, accelerate recuperation periods, and improve healthcare outcomes.

It is anticipated that North America will hold the largest market share of the worldwide thoracic drainage systems market. The region's stronghold over technological advancements, sophisticated healthcare infrastructure, and high prevalence of respiratory disorders collectively contribute to this dominance. Healthcare systems that are firmly established in nations such as the US, and Canada foster an environment that is favourable for the integration of advanced medical technologies, such as thoracic drainage systems. It is expected that the Asia Pacific region will witness the most rapid expansion in the worldwide market for thoracic drainage systems. A multitude of factors contribute to this exponential growth. In densely populated nations such as China, and India, the rising incidence of respiratory maladies is the primary driver of demand for thoracic interventions, such as chest drainage systems. Enhancement of healthcare infrastructure, economic growth, and increased healthcare consciousness are critical factors in enabling the region to avail itself of cutting-edge medical remedies.

Major market players included in this report are:

  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Smiths Medical (ICU Medical Inc.)
  • Becton, Dickinson and Company
  • Cardinal Health
  • Redax S.p.A.
  • Merit Medical Systems
  • Getinge AB
  • Rocket Medical plc.
  • Grena Ltd.
  • Sterimed Group
  • pfm medical ag
  • Medela AG
  • Sinapi Biomedical
  • ATMOS MedizinTechnik GmbH & Co. KG

The detailed segments and sub-segment of the market are explained below:

By Product:

  • Pleural Drainage Systems
  • Pleural Drainage Systems Kits
  • Pleural Drainage Systems Accessories

By Indication:

  • Pleural Effusion
  • Hemothorax
  • Spontaneous Pneumothorax
  • Tension Pneumothorax
  • Traumatic Pneumothorax
  • Cardiac Tamponade
  • Coronary Artery Bypass Grafting (CABG) Procedures
  • Open Heart Surgeries

By End-user:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Chest Drainage Systems Market Executive Summary

  • 1.1. Global Chest Drainage Systems Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product
    • 1.3.2. By Indication
    • 1.3.3. By End-user
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Chest Drainage Systems Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Chest Drainage Systems Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increasing Prevalence of Respiratory Conditions
    • 3.1.2. Technological Advancements
    • 3.1.3. Demand for Minimally Invasive Procedures
  • 3.2. Market Challenges
    • 3.2.1. High Cost of Advanced Systems
    • 3.2.2. Lack of Skilled Professionals
  • 3.3. Market Opportunities
    • 3.3.1. Growing Geriatric Population
    • 3.3.2. Expansion in Emerging Markets

Chapter 4. Global Chest Drainage Systems Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Chest Drainage Systems Market Size & Forecasts by Product 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Chest Drainage Systems Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Pleural Drainage Systems
    • 5.2.2. Pleural Drainage Systems Kits
    • 5.2.3. Pleural Drainage Systems Accessories

Chapter 6. Global Chest Drainage Systems Market Size & Forecasts by Indication 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Chest Drainage Systems Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Pleural Effusion
    • 6.2.2. Hemothorax
    • 6.2.3. Spontaneous Pneumothorax
    • 6.2.4. Tension Pneumothorax
    • 6.2.5. Traumatic Pneumothorax
    • 6.2.6. Cardiac Tamponade
    • 6.2.7. Coronary Artery Bypass Grafting (CABG) Procedures
    • 6.2.8. Open Heart Surgeries

Chapter 7. Global Chest Drainage Systems Market Size & Forecasts by End-user 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Chest Drainage Systems Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Hospitals
    • 7.2.2. Specialty Clinics
    • 7.2.3. Ambulatory Surgical Centers

Chapter 8. Global Chest Drainage Systems Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Chest Drainage Systems Market
    • 8.1.1. U.S. Chest Drainage Systems Market
      • 8.1.1.1. Product breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Indication breakdown size & forecasts, 2022-2032
      • 8.1.1.3. End-user breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Chest Drainage Systems Market
  • 8.2. Europe Chest Drainage Systems Market
    • 8.2.1. UK Chest Drainage Systems Market
    • 8.2.2. Germany Chest Drainage Systems Market
    • 8.2.3. France Chest Drainage Systems Market
    • 8.2.4. Spain Chest Drainage Systems Market
    • 8.2.5. Italy Chest Drainage Systems Market
    • 8.2.6. Rest of Europe Chest Drainage Systems Market
  • 8.3. Asia Pacific Chest Drainage Systems Market
    • 8.3.1. China Chest Drainage Systems Market
    • 8.3.2. India Chest Drainage Systems Market
    • 8.3.3. Japan Chest Drainage Systems Market
    • 8.3.4. Australia Chest Drainage Systems Market
    • 8.3.5. South Korea Chest Drainage Systems Market
    • 8.3.6. Rest of Asia Pacific Chest Drainage Systems Market
  • 8.4. Latin America Chest Drainage Systems Market
    • 8.4.1. Brazil Chest Drainage Systems Market
    • 8.4.2. Mexico Chest Drainage Systems Market
    • 8.4.3. Rest of Latin America Chest Drainage Systems Market
  • 8.5. Middle East & Africa Chest Drainage Systems Market
    • 8.5.1. Saudi Arabia Chest Drainage Systems Market
    • 8.5.2. South Africa Chest Drainage Systems Market
    • 8.5.3. Rest of Middle East & Africa Chest Drainage Systems Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Teleflex Incorporated
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. B. Braun Melsungen AG
    • 9.3.3. Smiths Medical (ICU Medical Inc.)
    • 9.3.4. Becton, Dickinson and Company
    • 9.3.5. Cardinal Health
    • 9.3.6. Redax S.p.A.
    • 9.3.7. Merit Medical Systems
    • 9.3.8. Getinge AB
    • 9.3.9. Rocket Medical plc.
    • 9.3.10. Grena Ltd.
    • 9.3.11. Sterimed Group
    • 9.3.12. pfm medical ag
    • 9.3.13. Medela AG
    • 9.3.14. Sinapi Biomedical
    • 9.3.15. ATMOS MedizinTechnik GmbH & Co. KG

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦